COLGATE PALMOLIVE CO (CL) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-03

Key Insights

Insider Lorrie M. Norrington, a director of Colgate-Palmolive, has acquired 294 shares of the company's common stock at $89.05 per share, increasing her direct beneficial ownership to 40,160 shares.
This purchase suggests Norrington's confidence in Colgate-Palmolive's future performance and aligns her interests with those of shareholders.
The timing of the transaction, occurring in early April 2026, may indicate Norrington's positive outlook on the company's upcoming quarterly or annual results.

Want the newest filings?

This analysis covers the filing from 2026-04-03. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-03

Insider Brian Newman acquired 210 shares of Colgate-Palmolive stock, increasing his direct ownership to 5,534 shares.
Newman also owns an additional 36 shares indirectly through a family trust, indicating his alignment with the company's long-term success.
The purchase price of $89.05 per share suggests Newman views the stock as undervalued and has confidence in Colgate-Palmolive's future performance.

Filed: 2026-04-03

John P. Bilbrey, a director of Colgate-Palmolive, acquired 266 shares of the company's common stock at $89.05 per share, increasing his direct ownership to 37,665 shares.
Bilbrey also has an indirect ownership of 4,719 shares held in a trust, indicating his commitment to the company.
The transaction appears to be a routine deferral of a portion of Bilbrey's annual cash retainer into a stock unit account, which is a common practice for non-employee directors.

Filed: 2026-02-25

The reporting person, Panagiotis Tsourapas, acquired 25,742 shares of Colgate-Palmolive's common stock through the vesting of performance-based restricted stock units (PBRSUs) under the company's incentive compensation plan.
Tsourapas also disposed of 13,081 shares to cover tax liabilities incident to the vesting of the PBRSUs, resulting in a net direct ownership of 21,629 shares of common stock.
In addition to his direct ownership, Tsourapas also has indirect beneficial ownership of 4,568 shares through the company's 401(k) plan and 62,240 shares through a trust, for a total beneficial ownership of 88,437 shares.

Filed: 2026-02-25

John Hazlin, the Chief Growth Officer, acquired 12,803 shares of Colgate-Palmolive through vesting of performance-based restricted stock units (PBRSUs), indicating the company's confidence in his leadership.
Hazlin also disposed of 6,117 shares to cover tax liabilities, suggesting he maintains a significant direct ownership stake in the company.
The transaction is part of the company's incentive compensation plan, aligning the executive's interests with shareholders.

Filed: 2026-02-25

The reporting person, Jennifer Daniels, acquired 25,742 shares of Colgate-Palmolive common stock through the vesting of performance-based restricted stock units (PBRSUs) under the company's incentive compensation plan.
Daniels also disposed of 12,351 shares through a tax withholding transaction related to the PBRSU vesting, indicating she is maintaining a significant direct ownership position in the company.
The PBRSU awards are likely tied to the achievement of pre-established performance goals, suggesting Daniels' compensation is aligned with shareholder value creation.

Filed: 2026-02-25

The reporting person, Malcolm Gregory, the EVP and Controller of Colgate-Palmolive Co, has acquired 6,268 shares of the company's common stock through the vesting of previously granted performance-based restricted stock units (PBRSUs).
Gregory has also disposed of 2,260 shares to cover the tax liability incident to the PBRSU vesting, leaving him with a direct ownership of 15,898 shares in the company.
Gregory also has an indirect ownership of 8,554 shares through the company's 401(k) plan, indicating a significant total beneficial ownership position in Colgate-Palmolive.

Filed: 2026-02-25

The reporting person, Sally Massey, acquired 16,805 shares of Colgate-Palmolive common stock through the vesting of previously-granted performance-based restricted stock units (PBRSUs).
Massey also disposed of 8,206 shares to cover tax liabilities associated with the PBRSU vesting, leaving her with a net increase of 8,599 shares in her direct holdings.
The reporting indicates ongoing equity-based compensation and incentive alignment between the executive and the company.

Filed: 2026-02-25

The reported transaction indicates that the Chief Financial Officer, Stanley J. Sutula III, has acquired 38,678 shares of Colgate-Palmolive's common stock through the vesting of performance-based restricted stock units.
Sutula also disposed of 19,746 shares to cover tax liabilities related to the vesting, indicating a net increase in his direct ownership of Colgate-Palmolive shares.
The transactions suggest Sutula's continued commitment to and confidence in Colgate-Palmolive, as he maintains a significant direct ownership position in the company's stock.

Filed: 2026-02-25

Noel R. Wallace, the Chairman, President, and CEO of Colgate-Palmolive, has acquired a substantial number of shares through the vesting of performance-based restricted stock units, indicating his confidence in the company's future performance.
Wallace has also disposed of a portion of his shares through tax withholding, which is a common practice to cover tax liabilities associated with such equity awards.
The filing shows that Wallace holds a significant amount of Colgate-Palmolive stock, both directly and indirectly through the company's 401(k) plan and a trust, aligning his interests with those of shareholders.

Filed: 2026-02-13

Insider Panagiotis Tsourapas, the COO of Europe, Asia Pacific, and Africa, has exercised 50,000 stock options and sold 50,000 shares of Colgate-Palmolive stock over the past two trading days.
The reported transactions were executed pursuant to a 10b5-1 trading plan, indicating they were pre-planned and not based on inside information.
The sale prices of $94.61 and $97.81 per share suggest the insider is taking advantage of the stock's recent price appreciation, but still maintains a sizable direct ownership position of 10,415 shares.

Filed: 2026-02-12

The reporting person, John Hazlin, exercised 20,989 stock options and immediately sold the underlying shares, netting a profit of $17.85 per share.
Hazlin's total direct ownership of Colgate-Palmolive common stock decreased from 38,634 shares to 17,645 shares as a result of this transaction.
Hazlin also holds an indirect beneficial ownership of 5,452 shares through the company's 401(k) plan.

Filed: 2026-02-10

Malcolm Gregory, the EVP and Controller of Colgate-Palmolive, exercised 12,747 stock options and sold 12,747 shares at an average price of $94.91 per share, indicating he is monetizing a portion of his equity compensation.
The reported transaction was made pursuant to a Rule 10b5-1 trading plan, which suggests the sales were part of a pre-determined strategy rather than opportunistic.
The reporting person continues to hold 11,879 shares of Colgate-Palmolive stock directly, as well as an additional 8,554 shares held indirectly through the company's 401(k) plan, indicating he maintains a substantial ownership stake in the company.

Filed: 2026-02-09

The reporting person, Sally Massey, exercised 15,851 stock options and immediately sold 15,851 shares, suggesting potential insider selling activity.
The sale of shares was executed at a weighted average price of $95.0279, representing a gain over the exercise price of $76.41 per share.
The reporting person continues to hold 13,751 shares of Colgate-Palmolive's common stock directly, as well as 8,111 shares indirectly through the issuer's 401(k) plan.

Other reports for COLGATE PALMOLIVE CO

Quarterly Report Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.